Urology
Volume 59, Issue 6 , Pages 870-876 , June 2002

Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome1

  • Kathleen J Propert

      Affiliations

    • Corresponding Author InformationReprint requests: Kathleen Joy Propert, Sc.D., Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Blockley Hall, Room 614, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA
    • Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    • ,
  • Richard B Alexander

      Affiliations

    • University of Maryland, Baltimore, Maryland, USA
    • ,
  • J.Curtis Nickel

      Affiliations

    • Queen’s University, Kingston, Ontario, Canada
    • ,
  • John W Kusek

      Affiliations

    • National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, Maryland, USA
    • ,
  • Mark S Litwin

      Affiliations

    • University of California, Los Angeles, School of Medicine, Los Angeles, California, USA
    • ,
  • J.Richard Landis

      Affiliations

    • Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    • ,
  • Leroy M Nyberg

      Affiliations

    • National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, Maryland, USA
    • ,
  • Anthony J Schaeffer

      Affiliations

    • Northwestern University, Chicago, Illinois, USA
    • ,
  • Chronic Prostatitis Collaborative Research Network

Received 10 October 2001 ,Revised 29 January 2002 ,Accepted 29 January 2002.

References 

  1. Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236–237
  2. Krieger JN, Egan KJ, Ross SO, et al.  Chronic pelvic pains represent the most prominent urogenital symptoms of “chronic prostatitis.”. Urology. 1996;48:715–721
  3. Egan KJ, Krieger JL. Chronic abacterial prostatitis—a urological chronic pain syndrome?. Pain. 1997;69:213–218
  4. McNaughton-Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis (a systematic review). Ann Intern Med. 2000;133:367–381
  5. Schaeffer AJ, Landis JR, Knauss JS, et al, and the CPCRN Study Group: Demographic and clinical characteristics of men with chronic prostatitis: the NIH Chronic Prostatitis Cohort (CPC) study. J Urol (in press).
  6. Schaeffer AJ, Knauss JS, Landis JR, et al: Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the NIH chronic prostatitis cohort (CPC) study. J Urol (in press).
  7. Nickel JC, Nyberg L, Hennenfent M. Research guidelines for chronic prostatitis (a consensus report from the First National Institutes of Health-International Prostatitis Collaborative Network (NIH-IPCN)). Urology. 1999;54:229–233
  8. Chronic Prostatitis Collaborative Research Network Litwin MS, McNaughton-Collins M, Fowler FJ, et al.  The National Institutes of Health Chronic Prostatitis Symptom Index (development and validation of a new outcome measure). J Urol. 1999;162:369–375
  9. Chronic Prostatitis Collaborative Research Network McNaughton-Collins M, O’Leary MP, Calhoun EA, et al.  The Spanish NIH-chronic prostatitis symptom index (translation and linguistic validation). J Urol. 2001;166:1800–1803
  10. Nickel JC, McNaughton-Collins M, Litwin SM. Development and use of a validated outcome measure for prostatitis. J Clin Outcomes Manag. 2001;8:30–37
  11. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey—construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
  12. Meares E, Stamey T. Bacterial localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5:492–518
  13. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York: Oxford University Press; 1994;
  14. Schaeffer AJ, Wendel EF, Dunn JK, et al.  Prevalence and significance of prostatic inflammation. J Urol. 1981;125:215–219
  15. In:  Guess HA,  Kleinman A,  Kusek JW, et al. editor. The Science of the Placebo (Toward an Interdisciplinary Research Agenda). London: BMJ Books; 2002;
  16. McNaughton-Collins M, Fowler FJ, Elliott DB, et al.  Diagnosing and treating chronic prostatitis (do urologists use the four-glass test?). Urology. 2000;55:403–407
  17. Moon TD. Questionnaire survey of urologists and primary care physicians’ diagnostic and treatment practices for prostatitis. Urology. 1997;50:543–547
  18. Weidner W, Ludwig M, Brahler E, et al.  Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs. 1999;58(suppl 2):103–106
  19. German Prostatitis Study Group Naber KG, Busch W, Focht J. Ciprofloxacin in the treatment of chronic bacterial prostatitis (a prospective, non-comparative multicentre clinical trial with long-term follow-up). Int J Antimicrob Agents. 2000;14:143–149
  20. Canadian Prostatitis Research Group Nickel JC, Downey J, Johnston B, et al.  Predictors of response to antibiotic therapy for chronic prostatitis/chronic pelvic pain syndrome (a prospective multicenter clinical study). J Urol. 2001;165:1539–1544
  21. Berger RE, Krieger JN, Rothman I, et al.  Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol. 1997;157:863–865
  22. Shoskes DA, Shahed AR. Detection of bacterial signal by 16s rRNA polymerase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pelvic pain syndrome. Tech Urol. 2000;6:240–242
  23. Krieger JN, Riley DE, Roberts MC, et al.  Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol. 1996;34:3120–3128
  24. Nadler RB, Koch AE, Calhoun EA, et al.  IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000;164:214–218
  25. Alexander RB, Ponniah S, Hasday J, et al.  Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 1998;52:744–749
  26. Galley HF, Nelson SJ, Dubbels AM, et al.  Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med. 1997;25:1392–1395
  27. Yoshimura T, Kurita C, Usami E, et al.  Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells. Chemotherapy. 1996;42:459–464
  28. Shahed AR, Shoskes DA. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome (correlation with gram positive bacterial growth and treatment response). J Androl. 2000;21:669–675
  29. De la Rosette JJ, Karthaus HF, van Kerrebroeck PE, et al.  Research in prostatitis syndromes (the use of alfuzosin in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities). Eur Urol. 1992;22:222–227
  30. Dunzendorfer U, Kruschwitz K, Letzel H. Effects of phenoxybenzamine on clinical picture, laboratory test results and spermatogram in chronic abacterial prostatitis. Therapiewoche. 1983;33:4694–4705
  31. Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol. 1998;159:883–887

☆ This study was supported by grants R01 DK53736, R01 DK53752, R01 DK53732, R01 DK53730, R01 DK53734, and R01 DK53746 from the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

PII: S0090-4295(02)01601-1

Urology
Volume 59, Issue 6 , Pages 870-876 , June 2002

Article Tools